Sonoma Pharmaceuticals Statistics
Total Valuation
SNOA has a market cap or net worth of $5.36 million. The enterprise value is $3.80 million.
Important Dates
The last earnings date was Tuesday, June 16, 2026, after market close.
| Earnings Date | Jun 16, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SNOA has 4.79 million shares outstanding. The number of shares has increased by 35.70% in one year.
| Current Share Class | 4.79M |
| Shares Outstanding | 4.79M |
| Shares Change (YoY) | +35.70% |
| Shares Change (QoQ) | +1.28% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 1.43% |
| Float | 4.77M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.27 |
| Forward PS | 0.25 |
| PB Ratio | 0.65 |
| P/TBV Ratio | 1.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 0.19 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.50, with a Debt / Equity ratio of 0.27.
| Current Ratio | 2.50 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.27 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -84.60% and return on invested capital (ROIC) is -35.55%.
| Return on Equity (ROE) | -84.60% |
| Return on Assets (ROA) | -11.12% |
| Return on Invested Capital (ROIC) | -35.55% |
| Return on Capital Employed (ROCE) | -26.96% |
| Weighted Average Cost of Capital (WACC) | 9.83% |
| Revenue Per Employee | $1.95M |
| Profits Per Employee | -$317,500 |
| Employee Count | 10 |
| Asset Turnover | 1.41 |
| Inventory Turnover | 3.69 |
Taxes
| Income Tax | -244,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.54% in the last 52 weeks. The beta is 1.30, so SNOA's price volatility has been higher than the market average.
| Beta (5Y) | 1.30 |
| 52-Week Price Change | -61.54% |
| 50-Day Moving Average | 1.26 |
| 200-Day Moving Average | 2.82 |
| Relative Strength Index (RSI) | 42.95 |
| Average Volume (20 Days) | 145,452 |
Short Selling Information
The latest short interest is 45,360, so 0.95% of the outstanding shares have been sold short.
| Short Interest | 45,360 |
| Short Previous Month | 27,047 |
| Short % of Shares Out | 0.95% |
| Short % of Float | 0.95% |
| Short Ratio (days to cover) | 0.33 |
Income Statement
In the last 12 months, SNOA had revenue of $19.53 million and -$3.18 million in losses. Loss per share was -$1.89.
| Revenue | 19.53M |
| Gross Profit | 7.42M |
| Operating Income | -2.46M |
| Pretax Income | -3.42M |
| Net Income | -3.18M |
| EBITDA | -2.32M |
| EBIT | -2.46M |
| Loss Per Share | -$1.89 |
Full Income StatementBalance Sheet
The company has $2.40 million in cash and $842,000 in debt, giving a net cash position of $1.56 million or $0.33 per share.
| Cash & Cash Equivalents | 2.40M |
| Total Debt | 842,000 |
| Net Cash | 1.56M |
| Net Cash Per Share | $0.33 |
| Equity (Book Value) | 3.10M |
| Book Value Per Share | 1.72 |
| Working Capital | 7.27M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$3.93 million and capital expenditures -$192,000, giving a free cash flow of -$4.13 million.
| Operating Cash Flow | -3.93M |
| Capital Expenditures | -192,000 |
| Depreciation & Amortization | 139,000 |
| Net Borrowing | 6,000 |
| Free Cash Flow | -4.13M |
| FCF Per Share | -$0.86 |
Full Cash Flow StatementMargins
Gross margin is 37.97%, with operating and profit margins of -12.60% and -16.26%.
| Gross Margin | 37.97% |
| Operating Margin | -12.60% |
| Pretax Margin | -17.51% |
| Profit Margin | -16.26% |
| EBITDA Margin | -11.89% |
| EBIT Margin | -12.60% |
| FCF Margin | n/a |